Hypolipidemic effects of bezafibrate: studies in Italy.
D001629:Bezafibrate / Q000378:metabolism / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D004311:Double-Blind Method; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy; D006951:Hyperlipoproteinemias / Q000097:blood / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D011897:Random Allocation
D008055:Lipids; D008074:Lipoproteins; D002994:Clofibrate; D001629:Bezafibrate